$3.03 Billion is the total value of BRAIDWELL LP's 81 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 39.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GUARDANT HEALTH INCnote 11/1 | $168,847,260 | +7.7% | 250,022,000 | 0.0% | 5.57% | +6.0% | ||
| EXACT SCIENCES CORPnote 0.375% 3/0 | $122,748,869 | +12.0% | 139,000,000 | 0.0% | 4.05% | +10.2% | ||
| NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $121,832,851 | +3.1% | 145,520,000 | 0.0% | 4.02% | +1.4% | ||
| Buy | NOVOCURE LTDnote 11/0 | $116,802,148 | -0.7% | 134,334,000 | +1.9% | 3.85% | -2.2% | |
| Sell | ALPHATEC HLDGS INCnote 0.750% 8/0 | $108,210,938 | +4.9% | 101,250,000 | -9.8% | 3.57% | +3.3% | |
| Buy | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $106,213,458 | +66.8% | 143,338,000 | +1.3% | 3.50% | +64.2% | |
| NEVRO CORPnote 2.750% 4/0 | $102,695,940 | +2.5% | 109,251,000 | 0.0% | 3.39% | +0.8% | ||
| GKOS | Buy | GLAUKOS CORP | $90,513,215 | +24.7% | 1,806,651 | +8.7% | 2.98% | +22.7% |
| ISEE | Buy | IVERIC BIO INC | $90,377,970 | +26.3% | 3,714,672 | +11.2% | 2.98% | +24.4% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $77,615,496 | – | 766,800 | +100.0% | 2.56% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $76,487,167 | +25.3% | 2,137,110 | +38.0% | 2.52% | +23.3% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $69,210,418 | +49.2% | 207,130 | -5.8% | 2.28% | +46.9% |
| BIIB | Sell | BIOGEN INC | $61,372,898 | -12.2% | 220,742 | -12.6% | 2.02% | -13.7% |
| NVRO | Buy | NEVRO CORP | $59,029,877 | +25.0% | 1,632,915 | +37.0% | 1.95% | +23.1% |
| ISRG | INTUITIVE SURGICAL INC | $57,000,466 | -3.7% | 223,120 | 0.0% | 1.88% | -5.2% | |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $56,330,581 | +20.8% | 454,169 | -8.7% | 1.86% | +19.0% |
| NTRA | Sell | NATERA INC | $54,534,020 | -16.3% | 982,241 | -39.4% | 1.80% | -17.6% |
| Buy | TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $53,901,491 | +15.5% | 56,031,000 | +10.9% | 1.78% | +13.8% | |
| Buy | NUVASIVE INCnote 1.000% 6/0 | $51,148,812 | +215.1% | 51,500,000 | +212.1% | 1.69% | +210.1% | |
| KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $51,148,346 | +3.6% | 65,976,000 | 0.0% | 1.69% | +2.0% | ||
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $50,078,873 | -6.6% | 3,241,351 | -0.9% | 1.65% | -8.1% |
| PCVX | Sell | VAXCYTE INC | $49,472,775 | -24.3% | 1,319,978 | -3.1% | 1.63% | -25.4% |
| IONIS PHARMACEUTICALS INCnote 4/0 | $48,125,250 | -1.7% | 52,740,000 | 0.0% | 1.59% | -3.2% | ||
| EXACT SCIENCES CORPnote 0.375% 3/1 | $45,183,667 | +12.7% | 48,300,000 | 0.0% | 1.49% | +10.9% | ||
| KIDS | Sell | ORTHOPEDIATRICS CORP | $44,239,997 | +6.6% | 998,871 | -4.4% | 1.46% | +4.9% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $42,247,796 | +57.5% | 3,159,895 | +153.5% | 1.39% | +54.9% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $41,989,256 | +177.0% | 1,038,310 | +218.7% | 1.38% | +172.6% |
| AMYRIS INCnote 1.500%11/1 | $39,080,475 | -9.6% | 137,850,000 | 0.0% | 1.29% | -11.0% | ||
| AMGN | Buy | AMGEN INC | $39,042,625 | +13.4% | 161,500 | +23.2% | 1.29% | +11.6% |
| Sell | INSMED INCnote 1.750% 1/1 | $36,486,219 | -3.1% | 39,963,000 | -90.0% | 1.20% | -4.7% | |
| NEOGENOMICS INCnote 0.250% 1/1 | $36,021,720 | +12.8% | 48,678,000 | 0.0% | 1.19% | +10.9% | ||
| IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $33,800,477 | +1.3% | 36,533,000 | 0.0% | 1.12% | -0.3% | ||
| NUVASIVE INCnote 0.375% 3/1 | $32,466,858 | +0.8% | 36,665,000 | 0.0% | 1.07% | -0.7% | ||
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $32,436,607 | -48.9% | 2,019,714 | -41.8% | 1.07% | -49.7% |
| OM | Buy | OUTSET MED INC | $32,280,040 | -26.7% | 1,754,350 | +2.9% | 1.06% | -27.8% |
| Sell | NEOGENOMICS INCnote 1.250% 5/0 | $30,958,125 | -15.1% | 33,000,000 | -23.3% | 1.02% | -16.4% | |
| HROW | New | HARROW HEALTH INC | $30,735,704 | – | 1,452,538 | +100.0% | 1.01% | – |
| PEN | Sell | PENUMBRA INC | $29,832,092 | -17.6% | 107,044 | -34.3% | 0.98% | -18.9% |
| BLU | Buy | BELLUS HEALTH INC NEW | $29,708,597 | -12.1% | 4,126,194 | +0.3% | 0.98% | -13.5% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $29,018,844 | -11.7% | 601,801 | -8.6% | 0.96% | -13.1% |
| Buy | DICE THERAPEUTICS INC | $28,214,520 | +7.8% | 984,800 | +17.4% | 0.93% | +6.2% | |
| Sell | TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $27,868,050 | -2.8% | 28,350,000 | -9.6% | 0.92% | -4.4% | |
| KRYS | Sell | KRYSTAL BIOTECH INC | $27,863,762 | -1.8% | 348,036 | -2.8% | 0.92% | -3.4% |
| BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $27,379,090 | +69.5% | 42,294,000 | 0.0% | 0.90% | +66.9% | ||
| MRUS | Sell | MERUS N V | $27,104,746 | -12.3% | 1,473,084 | -26.3% | 0.89% | -13.7% |
| HILLEVAX INC | $26,782,170 | -1.2% | 1,620,216 | 0.0% | 0.88% | -2.8% | ||
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $26,446,970 | -29.9% | 3,269,094 | +36.6% | 0.87% | -31.0% |
| TERN | New | TERNS PHARMACEUTICALS INC | $23,645,131 | – | 1,997,055 | +100.0% | 0.78% | – |
| ANAB | Buy | ANAPTYSBIO INC | $21,174,068 | -5.9% | 973,073 | +34.0% | 0.70% | -7.4% |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $21,066,878 | – | 426,110 | +100.0% | 0.70% | – |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $20,462,157 | +10.5% | 12,107,785 | 0.0% | 0.68% | +8.7% | |
| ALEC | Buy | ALECTOR INC | $19,847,090 | +196.6% | 3,206,315 | +342.2% | 0.66% | +192.4% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $19,431,435 | -38.6% | 920,049 | -26.0% | 0.64% | -39.5% |
| GMED | Sell | GLOBUS MED INCcl a | $18,985,728 | -25.6% | 335,200 | -2.5% | 0.63% | -26.8% |
| New | PARAGON 28 INC | $18,755,185 | – | 1,098,722 | +100.0% | 0.62% | – | |
| STE | STERIS PLC | $18,304,348 | +3.6% | 95,694 | 0.0% | 0.60% | +2.0% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $16,805,360 | -10.3% | 452,000 | +9.3% | 0.55% | -11.8% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $16,222,418 | – | 1,945,134 | +100.0% | 0.54% | – |
| DYN | Buy | DYNE THERAPEUTICS INC | $15,873,085 | +81.8% | 1,377,872 | +82.9% | 0.52% | +78.8% |
| Sell | INVITAE CORPnote 2.000% 9/0 | $14,842,012 | -12.9% | 16,781,000 | -21.9% | 0.49% | -14.2% | |
| VIR | New | VIR BIOTECHNOLOGY INC | $14,055,918 | – | 604,036 | +100.0% | 0.46% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $13,792,359 | +26.4% | 3,355,805 | +80.2% | 0.46% | +24.3% |
| LUNG | Sell | PULMONX CORP | $13,005,627 | -4.9% | 1,163,294 | -28.3% | 0.43% | -6.3% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $12,706,734 | – | 1,097,300 | +100.0% | 0.42% | – |
| CMPX | Buy | COMPASS THERAPEUTICS INC | $10,620,460 | +16.4% | 3,247,847 | +79.0% | 0.35% | +14.4% |
| New | ARCELLX INC | $10,284,378 | – | 333,800 | +100.0% | 0.34% | – | |
| ARGX | Sell | ARGENX SEsponsored adr | $9,165,468 | -50.8% | 24,600 | -50.0% | 0.30% | -51.7% |
| AXNX | New | AXONICS INC | $9,095,370 | – | 166,704 | +100.0% | 0.30% | – |
| New | MINERALYS THERAPEUTICS INC | $8,617,698 | – | 550,300 | +100.0% | 0.28% | – | |
| TMDX | Sell | TRANSMEDICS GROUP INC | $7,456,300 | -60.2% | 98,459 | -67.5% | 0.25% | -60.8% |
| NUVB | NUVATION BIO INC | $6,844,014 | -13.5% | 4,122,900 | 0.0% | 0.23% | -14.7% | |
| SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $6,515,368 | +1.5% | 6,500,000 | 0.0% | 0.22% | 0.0% | ||
| ADPT | New | ADAPTIVE BIOTECHNOLOGIES COR | $5,725,822 | – | 648,451 | +100.0% | 0.19% | – |
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $5,649,548 | +94.1% | 1,249,900 | +383.9% | 0.19% | +89.8% |
| Sell | INSMED INCnote 0.750% 6/0 | $2,721,080 | -67.2% | 3,500,000 | -65.0% | 0.09% | -67.6% | |
| SILK | Sell | SILK RD MED INC | $2,478,142 | -88.8% | 63,331 | -84.8% | 0.08% | -88.9% |
| IMTX | Sell | IMMATICS N.V | $2,223,780 | -79.6% | 322,287 | -74.2% | 0.07% | -80.0% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $1,926,315 | -90.9% | 1,211,519 | -64.3% | 0.06% | -91.0% |
| REPL | Sell | REPLIMUNE GROUP INC | $1,300,924 | -92.8% | 73,665 | -88.9% | 0.04% | -92.9% |
| New | ILLUMINA INCnote 8/1 | $1,087,736 | – | 11,100,000 | +100.0% | 0.04% | – | |
| New | AVALO THERAPEUTICS INC | $432,695 | – | 247,254 | +100.0% | 0.01% | – | |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -71,585 | -100.0% | -0.05% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -620,280 | -100.0% | -0.05% | – |
| Exit | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $0 | – | -381,120 | -100.0% | -0.13% | – | |
| MIST | Exit | MILESTONE PHARMACEUTICALS IN | $0 | – | -1,164,849 | -100.0% | -0.16% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -2,000,000 | -100.0% | -0.21% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -914,209 | -100.0% | -0.22% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -920,304 | -100.0% | -0.26% | – |
| NKTX | Exit | NKARTA INC | $0 | – | -1,525,800 | -100.0% | -0.31% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -313,403 | -100.0% | -0.31% | – |
| Exit | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $0 | – | -9,000,000 | -100.0% | -0.32% | – | |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -927,800 | -100.0% | -0.34% | – |
| COO | Exit | COOPER COS INC | $0 | – | -52,115 | -100.0% | -0.58% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -3,474,497 | -100.0% | -0.58% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -235,319 | -100.0% | -0.59% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -140,352 | -100.0% | -0.61% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.66% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -389,596 | -100.0% | -0.68% | – |
| Exit | BIOMARIN PHARMACEUTICAL INCnote 1.250% 5/1 | $0 | – | -19,200,000 | -100.0% | -0.70% | – | |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,493,121 | -100.0% | -0.80% | – |
| Exit | QUIDELORTHO CORP | $0 | – | -300,437 | -100.0% | -0.86% | – | |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -1,455,585 | -100.0% | -1.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GUARDANT HEALTH INC | 4 | Q3 2023 | 6.3% |
| EXACT SCIENCES CORP | 4 | Q3 2023 | 4.4% |
| NOVOCURE LTD | 4 | Q3 2023 | 3.9% |
| NANOSTRING TECHNOLOGIES INC | 4 | Q3 2023 | 4.0% |
| NEVRO CORP | 4 | Q3 2023 | 3.4% |
| BRIDGEBIO PHARMA INC | 4 | Q3 2023 | 3.5% |
| ALPHATEC HLDGS INC | 4 | Q3 2023 | 3.6% |
| GLAUKOS CORP | 4 | Q3 2023 | 3.0% |
| VAXCYTE INC | 4 | Q3 2023 | 2.8% |
| XENON PHARMACEUTICALS INC | 4 | Q3 2023 | 2.5% |
View BRAIDWELL LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.